Association of ICU Admission Time, Age Stratification, and Clinical Frailty Scale With 30-Day Mortality in Geriatric Oncology Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Observation: Retrospective observational assessment of emergency department boarding time, Clinical Frailty Scale score, age stratification, and their association with 30-day mortality in geriatric oncology patients admitted to the Anesthesiology and Reanimation Intensive Care Unit.
Study summary
Geriatric oncology patients frequently require intensive care admission and are at increased risk of adverse outcomes due to advanced age, frailty, and critical illness. Delays in admission from the emergency department to the intensive care unit (ICU) may further contribute to poor prognosis. This retrospective cohort study aims to evaluate the association of ICU admission time, age stratification, and Clinical Frailty Scale (CFS) score with 30-day mortality among geriatric cancer patients admitted from the emergency department to the Anesthesiology and Reanimation Intensive Care Unit. Secondary objectives include assessing the relationship of these factors with intensive care unit length of stay, hospital length of stay, and in-hospital mortality. The findings may contribute to improved risk stratification and optimization of critical care management in geriatric oncology patients.
Eligibility
Primary outcome measure(s)
- 30-Day All-Cause Mortality — 30 days
All cause mortality within 30 days after admission to the Anesthesiology and Reanimation Intensive Care Unit
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ankara Dr. Abdurrahman Yurtaslan Oncolgy Training and Research Hospital | Yenimahalle | Ankara |
More Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07825090 on ClinicalTrials.gov ↗ ← All trials in Turkey